StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · HIT·Technology

Health In Tech, Inc. Stock Analysis & AI Score

Health In Tech, Inc. (HIT) has an ST Score of 45.7 (C+), driven by its Forecast (A) and held back by its Momentum (F). Analysts rate it Buy with a $3.50 price target (+310.0% upside).

Market Closed
$0.85
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
46
ST Score
45.7/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorTechnology
IndustrySoftware - Application
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

HIT
45.7out of 100
Grade C+

Health In Tech, Inc. (HIT) has an ST Score of 45.7 (C+), driven by its Forecast (A) and held back by its Momentum (F). Analysts rate it Buy with a $3.50 price target (+310.0% upside).

Strongest
ForecastA
Weakest
MomentumF
All factor grades
  • ForecastA
  • ValuationA-
  • Financial StrengthB+
  • GrowthB+
  • ProfitabilityD-
  • MomentumF
  • Piotroski0/9
Score methodology
Press Releases

Contact

HIT stock: frequently asked questions

What is HIT's ST Score?

Health In Tech, Inc. (HIT) has an ST Score of 45.7 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is HIT a buy, hold, or sell?

Analysts rate HIT a Buy, with a price target of $3.50 (+310.0% vs the current price). Our ST Score grades it C+ (45.7/100). The ST Score is a data-driven signal, not a recommendation.

What are HIT's factor grades?

Valuation A-, Profitability D-, Financial Strength B+, Momentum F, Growth B+, Forecast A.

What is HIT's valuation grade?

Health In Tech, Inc. (HIT) earns a valuation grade of A-, measured against Software - Application peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is HIT's growth grade?

Health In Tech, Inc. (HIT) earns a growth grade of B+, measured against Software - Application peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is HIT's profitability grade?

Health In Tech, Inc. (HIT) earns a profitability grade of D-, measured against Software - Application peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is HIT's financial strength grade?

Health In Tech, Inc. (HIT) earns a financial strength grade of B+, measured against Software - Application peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for HIT?

The average analyst price target for Health In Tech, Inc. (HIT) is $3.50 from 1 analysts, which is +310.0% versus the recent price of $0.85.

What is HIT's Piotroski score?

Health In Tech, Inc. (HIT) has a Piotroski F-Score of 0 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.